Surrogacy Market Size By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination {IUI}, In-vitro Fertilization {IVF} [Classical/Standard IVF, Intracytoplasmic Sperm Injection (ICSI)]), By Age Group (Below 35 Years, 35-37 Years, 38 - 39 Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics), COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027

Industry trends

Surrogacy Market size exceeded USD 4 billion in 2020 and is projected to achieve over 32.6% CAGR between 2021 and 2027.
 

Get more details on this report - Request Free Sample PDF
 

Surrogacy is a reproduction procedure wherein an arrangement is made for a surrogate to bear a child for intended parents. The procedure is legally backed. Surrogacy can be conducted traditionally or by gestational means. It has not been yet approved in all countries and the regulatory scenario is evolving with the passage of time. Recently, government of few countries including India have passed laws to allow surrogacy to help widows and divorced women apart from infertile homogenous and heterogenous couples. Such regulations coupled with growing awareness about availability of advanced reproductive technologies and alternatives will stimulate the global market growth during the forecast period.
 

COVID-19 pandemic hampered the overall number of surrogacies throughout the globe due to restrictions on non-emergency procedures. Couples who had started the cycle early in 2020 were not affected, however, new aspiring couples were quite affected owing to deferrals. With reduction in patient burden subsequently, the procedures regained traction and the surrogacy market is expected to momentously grow over the forecast period.

Growing burden of infertility attributed to the changing demographics will spur adoption of surrogacy

Rapidly increasing number of working women in emerging economies has shifted the childbearing age ahead. Progressing age along with several lifestyle changes negatively impacts fertility among women as well as men. In addition, habits such as alcoholism, smoking and consumption of calorie-rich diet affect fertility. With such faltering lifestyle, the ability to bear child is reducing, thereby increasing the prevalence of infertility.
 

Increasing inability to conceive has compelled reproductive medicine to advance in order to present several alternatives including surrogacy to support couples in having children. Sophisticated approaches including in-vitro fertilization, which has substantial success rate, have penetrated the market and are being rapidly adopted by numerous aspiring parents. Thus, market will foresee robust growth in the coming years. However, high cost of treatment in developed nations, especially in the U.S., can hinder the demand up to some extent.
 

Higher preference for gestational surrogacy will influence the segment growth

Gestational surrogacy being the most common type has gained significant demand in recent years. In gestational surrogacy procedure, the new-born is completely associated with the intended parent(s) genetically. The overall procedure is less complicated than traditional surrogacy. Gestational surrogacy has a proven greater success rate and will thus witness considerable growth in the coming years.
 

Superlative outcomes with in-vitro fertilization (IVF) procedure will enhance the segment expansion

IVF segment dominated more than 62% of the surrogacy market share in 2020. This technique of treating fertility is advanced and has higher success rate, leading to singleton or multiple pregnancies.
 

Various advances have been made in the IVF procedure including introduction of IVF with intracytoplasmic sperm injection (ICSI). IVF with ICSI is chiefly adopted in treatment of males having severe infertility issues. This technique has a success rate that ranges from 50 to 85%. With such high potential, the overall IVF market will foresee robust demand during the forecast timeline. 
 

Greater chances of conceiving among women aged below 35 years will positively impact the segment progression

Get more details on this report - Request Free Sample PDF

Below 35 years segment is poised to observe 33.2% growth rate through 2027. As per guidelines by the American Society for Reproductive Medicine (ASRM), an ideal surrogate must be a healthy woman preferably aged between 21 years and 35 years. Surrogacy carriers aged younger are a superior fit as fertility declines significantly after 30 years of age among women.
 

Growing investment in expansion of fertility clinics will augment their revenue growth

Fertility clinics segment was valued at USD 2.5 billion in 2020. Laws and regulations passed in favour of surrogacy have attracted stakeholders to invest in fertility centres and clinics. Clinics have improved their infrastructure along with fortification of portfolio including surrogacy services. This has increased the accessibility to the target population, thereby impelling the customer base and business size.
 

Availability of cost-effective surrogacy in Europe will propel the market revenue

Europe surrogacy market captured over 42% of revenue share in 2020. Various countries in the European region have permitted surrogacy procedures including Czech Republic, Greece, Russia, UK, Estonia, Greece and Georgia among few others. These countries have well-established infrastructure to conduct advanced technology-based procedures. People from some developed countries wherein surrogacy is expensive, seek treatment in such European countries due to cost-effectivity. Nations such as Estonia and Greece offer relatively affordable treatment, thereby increasing customer preference.
 

Acquisitions and facility expansion strategies are the being chiefly adopted by service providers to encash maximum growth opportunities

The global market consists of numerous players operating at regional and country-level including fertility clinics and hospitals. Few of the companies involved are IVIRMA, Circle Surrogacy, Nova and New Hope Fertility Clinic among various others. These providers are undertaking business growth strategies to broaden their market footprint.
 

Some of the recent industry developments:

• In January 2021, Triangle Capital Corporation announced its acquisition of Bourn Hall Ltd., a British fertility clinic. The acquisition will help the company in enhancing reach to its customers and offer business expansion opportunities.
   
• In September 2020, Inception Fertility introduced Pathways Fertility, a new network of clinics in Georgia. The new clinic, Pathways, offers services to couples with latest technology in reproductive medicine at affordable cost, thereby fostering their client base.  
   

The surrogacy market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

• Gestational surrogacy
• Traditional surrogacy

Market, By technology

• Intrauterine insemination (IUI)
• In-vitro fertilization (IVF)
  • Classical/standard IVF
  • Intracytoplasmic sperm injection (ICSI)
• Others

Market, By Age Group

• Below 35 years
• 35-37 years
• 38 - 39 years
• 40-42 years
• 43-44 years
• Over 44 years

Market, By Service Provider

• Hospitals
• Fertility clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Others
• Europe
  • Czech Republic
  • Estonia
  • Georgia
  • Greece
  • Poland
  • Russia
  • Sweden
  • Ukraine
  • UK
• Asia Pacific
  • India
  • Thailand
  • South Korea
• Africa
  • Kenya
  • Nigeria
  • South Africa